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Abstract 
The elaboration of biocompatible and biodegradable carriers for photosensitizer targeted delivery 
is one of the most promising approaches in a modern photodynamic therapy (PDT). This approach 
is aimed at reducing sides effects connected with incidental toxicity in healthy tissue whilst also 
enhancing drug accumulation in the tumour area. In the present work, Photosens-loaded calcium 
carbonate (CaCO3) submicron particles in vaterite modification are proposed as a novel platform 
for anticancer PDT. Fast penetration of the carriers (0.9±0.2 μm in diameter) containing 
0.12% (w/w) of the photosensitizer into NIH3T3/EGFP cells is demonstrated. The captured 
particles provide the dye localization inside the cell increasing its local concentration, compared 
with “free” Photosens solution which is uniformly distributed throughout the cell. The effect of 
photosensitizer encapsulation into vaterite submicron particles on cell viability under laser 
irradiation (670 nm, 19 mW/cm2, 10 minutes) is discussed in the work. As determined by a 
viability assay, the encapsulation renders Photosens more phototoxic. By this means, 
CaCO3 carriers allow improvement of the photosensitizer effectiveness supposing, therefore, the 
reduction of therapeutic dose. Summation of these effects with the simplicity, upscalability and 
cheapness of fabrication, biocompatibility and high payload ability of the vaterite particles hold 






 Vaterite particles are prospective biocompatible carriers for PDT. 
 The proposed carriers are capable of cellular uptake. 
 Encapsulation increases local PS concentration inside cells improving phototoxicity. 
 Vaterite particles encourage reduction of PS therapeutic dose. 
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Among the clinical methods of cancer treatment, photodynamic therapy (PDT) 
is gaining much interest, since such externally activatable treatment modality allows 
the selective cell destruction in pathologic area sparing the normal tissue. [1,2] This therapy 
requires administration of a photosensitizing agent, followed by irradiation with light at 
the wavelength corresponding to absorption maximum of the agent. Activated 
photosensitizer transfers the energy to molecular oxygen resulting in the generation of 
reactive oxygen species and initiating a sequence of photochemical reactions, which cause 
death of cancer cells and tumour tissue destruction. [3,4] Although PDT has proven as an 
effective approach to cancer treatment and significantly improves the survival time for 
many patients, it still offers great potential for further improvement [2,5]. The development 
of novel carriers for targeted delivery of photosensitizers is one of the most promising 
approaches in a modern PDT. [6–9] This approach might overcome many side effects 
associated with classic photodynamic therapy, including an incidental toxicity in healthy 
tissue, might enhance the drug accumulation in the tumour area, and, by this means, might 
improve the efficiency of the drug. Carriers such as liposomes [10–12], micelles [13,14], 
silica and calcium phosphate nanoparticles [15–17], quantum dots [18], polymeric and gold 
nanoparticles [19–21], have been previously applied for modification of various 
photosensitizers. Nevertheless, non-trivial storage conditions, instability, significant 
cytotoxicity and poor degradability, which are to different extents inherent to these 
materials, impede their application in biomedicine. Although a number of reports regard 
the inorganic nanomaterials with appropriate surface coatings as not notably toxic in vitro 
and in vivo in the tested dose ranges, it could still be extremely problematic for these agents 
to get FDA approval for clinical use. [1] The development of biocompatible and 
biodegradable carriers for anticancer PDT could thus be more clinically relevant. 
Prospective matrices for such a delivery system are calcium carbonate particles 
(CaCO3) in the form of vaterite, owing to its biocompatibility, large surface area and ability 
to decompose rapidly under mild conditions (pH below 6.5). [22–24] Such pH-sensitivity 
opens up new possibilities for targeted delivery, since the microenvironment in tumours 
is generally more acidic than in normal tissues. [25] High porosity of vaterite 
polycrystalline determines the high drug payload [26], that arouse interest toward the 
incorporation of various bioactive substances, like proteins [23,27,28], drugs [29,30] and 
DNA [31], into this matrix. By virtue of the fact, that vaterite is the least stable phase of 
calcium carbonate, and under the incubation in water-based solutions it gradually 
recrystallizes to stable calcite phase [32–34], such loaded particles release the drug without 
any external influence. Meanwhile, in the dried state the material shows high stability that 
enables long-term storage of the carriers at standard conditions. Biocompatibility tests for 
vaterite submicron-sized particles have demonstrated no indications of cytotoxicity and 
no influence on viability or metabolic activity in vitro. [35]  
Hereby, CaCO3 particle biodegradability, pH-sensitivity together with simplicity and 
cheapness of the fabrication technique hold out the prospect of its biomedical application, 
especially for novel PDT delivery system design. The additional tumour selectivity could 
be obtained through a particle surface modification, e.g. by attaching ligands interacting 
preferentially or specifically with tumour cells like monoclonal antibodies [36–38]. 
Previously, we have demonstrated the possibility of synthesizing micro- and submicron 
carriers for photosensitizer incorporation, whereupon we investigated the loading capacity 
of the carriers and a release mechanism depending on the surrounding pH. [24] However, 
efficiency of the treatment with such PDT containers still remains to be elucidated. 
Thereby, in this work we focused on the investigation of cellular uptake, cytotoxicity 
and influence on cell viability of photosensitizer-loaded porous CaCO3 submicron particles 
in the absence and presence of light irradiation. To our knowledge, this is the first study 
dealing with an in vitro phototoxicity of photosensitizer-loaded vaterite carriers. These 
studies could enable their use in targeted cancer treatment with reduced therapeutic dose of 
the drug. 
 
2. Experimental section 
2.1 Materials 
Calcium chloride (CaCl2) and sodium carbonate (Na2CO3) were purchased from Sigma-
Aldrich and used without further purification. Dulbecco's Modified Eagle Medium 
(DMEM) and phosphate-buffered saline (PBS), fetal bovine serum (FBS) and penicillin-
streptomycin were purchased from Life Technologies. Thiazolyl blue tetrazolium bromide 
(MTT), and Igepal CA-630 were also purchased from Sigma-Aldrich. 
The photosensitizer Photosens, a mixture of sulfonated aluminum phthalocyanines 
AlPcSn, with n = 2, 3 or 4 (the mean n = 3.1), was obtained from the Organic Intermediates 
and Dyes Institute (Moscow, Russia). It has an absorption maximum at 675 nm wavelength 
and induces the photodynamic effect in vivo under irradiation by an appropriate laser with 
light doses of 100-250 J/cm2. [39,40] The light doses of 1-15 J/cm2 (depending on a 
Photosens concentration) can activate the phototoxic effect of Photosens in vitro [40,41] 
Photosens is a well-known drug applied in clinical practice since 2001 (Registration 
Certificate Ministry of Health of Russian Federation No 000199.01-2001) in both 
diagnostics and treatment. [42–46] 
 
2.2 Container preparation and characterization 
For preparation of calcium carbonate particles, 5-ml volumes of 1 M Na2CO3 and 1 M 
CaCl2 water solutions were quickly added to 20 ml of deionized water in a glass vessel 
at room temperature and sonicated during 90 seconds by Ultrasonic Processor Gex-750 
(Manufacturer) at a frequency of 20 kHz and radiation power of 75 W. The synthesized 
CaCO3 particles were washed twice with water and once with ethanol and then freeze-dried. 
Photosens-loaded CaCO3 particles were prepared by a co-precipitation method. [47] 
The same procedure as for pure CaCO3 particles formation was used, with the only 
difference: 20 ml of 0.5 mg/ml Photosens solution was added instead of deionized water. 
To study the morphology and microstructure, dried particles were sputtered with gold 
and imaged with a scanning electron microscope (SEM), a MIRA II LMU (Tescan) at 
acceleration voltage of 20 kV and a Phillips XL 30 at 5-30 kV. 
Size distribution of particles was obtained by post processing and image analysis of 
SEM micrographs by Image J software (NIH, http://rsb.info.nih.gov/ij/). 
At least 4 overview SEM images per sample were used to collect 350 particle size 
measurements. The average size was shown as “mean ± standard deviation”. 
To study a crystallographic phase of pure and Photosens-loaded CaCO3 particle, X-ray 
diffraction patterns of the powders were obtained on Xcalibur/Gemini and PDS120 (Nonius 
GmbH, Solingen) diffractometer using Cu-Ka radiation. The accelerating voltage and the applied 
current were 40 kV and 40 mA, respectively. The theoretical CaCO3 spectra were taken from the 
works of Sitepu H. [48] and Le Bail A. [49] for calcite and vaterite, respectively. 
In order to estimate the mass of Photosens loaded into CaCO3 containers, their weighed 
portion was dissolved in aqueous solution of ethylenediaminetetracetic acid (EDTA, 
0.2 M). As a measure of the amount of Photosens in solution, a fluorescence intensity was 
recorded at 684 nm by a Cary Eclipse fluorescence spectrometer (Varian) with excitation 
at 633 nm. A calibration curve was obtained from the measurements of known 
concentrations of Photosens in EDTA solution. 
The loading capacity (%LC) of containers was estimated according to equation: 
% = 	 × 100%		(1) 
where 	  – the weight of Photosens incorporated into CaCO3 particles, 
 – the weight of CaCO3 particles. 
 
2.3 Release and recrystallization process 
To study the release of the drug, water and complete growth medium (DMEM supplemented 
with 10% inactivated FBS and 1% streptomycin–penicillin) were used. Vaterite containers loaded 
with Photosens were suspended in these solutions (6 mg of particles in 2 ml) and incubated at room 
temperature. After different incubation times (from 5 min to 7 days), the samples were centrifuged 
and the concentration of the released Photosens in the supernatant was measured by 
spectrofluorimetry using a Cary Eclipse fluorescence spectrometer (Varian). Then the measured 
solution was put back to the tube and incubated until the next measurement point. Calibration 
curves were obtained from the measurements of known concentrations of Photosens in both 
solution type (water and growth medium). To study the calcium carbonate phase change during 
the release process, samples were monitored by SEM, to accomplish this 2 μl of particle suspension 
was collected and dried before the examination. The calcium carbonate phases were judged 
according to their appearance: spherical for the polycrystalline vaterite (Figure 1) and cubic for 
calcite monocrystal (Figure 2 b, c). After the last measurement, the sediment was dissolved in 
EDTA and the concentration of Photosens in the supernatant was also measured to calculate an 
amount of the drug that remained in the particles during the experiment. 
 
2.4 Cell preparation and impregnation by containers 
For cell experiments, green fluorescent Swiss albino mouse embryo tissue cells 
(NIH3T3/EGFP) were used. NIH3T3 cells were transduced with a lentivirus that encodes 
EGFP from an SFFV promoter. Cells were sorted by flow cytometry to select a population 
that highly expressed EGFP. NIH3T3/EGFP cells were cultured in Dulbecco's Modified 
Eagle Medium supplemented with 10% inactivated Fetal Bovine Serum, 1% streptomycin–
penicillin and incubated at 37 °C under 5% CO2 atmosphere. The pH of the growth medium 
was in its normal range (7.2-7.4). For the confocal fluorescence investigation, 2x105 cells 
per dish (3.5 cm2 µDish, Ibidi) were incubated in 2 ml media overnight. For the cytotoxicity 
and viability assays, cells were seeded in a 96-multi well plate: 104 cells in 200 μl medium 
per well (0.32 cm2) – and incubated overnight. Pure CaCO3 particles, Photosens-loaded 
containers and Photosens solution were added then to cells and incubated for 24 hours. The 
concentration of added particles ( 	 ) was chosen based on the loaded drug 
amount ( 	 ), as corresponding to the median lethal dose of Photosens solution 
( 50 =3 μg/ml). [50] 
	 = 50 × 		(2) 
	 = 	
	 	 = 	
50
% × 100%		(3) 
where V – the volume of medium added to the cells, 	  – the weight of 
particles added to the cells calculated relying on equations (1) and (2). 
Hence, the concentration of CaCO3 particles added to the cells amounted to 0.25 mg/ml. 
Such concentration of the particles didn’t affect the pH of the growing media, assuming the 
colour of the media containing a phenol red indicator dye. 
2.5 Cellular uptake investigation 
To visualize viable cells and evaluate container uptake, a confocal laser scanning microscope 
Leica TCS SP5 (Leica, Germany) was used. After 24 hours of incubation with Photosens-loaded 
CaCO3 containers and Photosens solution, cell cultures were rinsed 3 times with PBS to remove 
free particles and free photosensitizer and thereafter were returned to growth medium. Confocal 
fluorescent images and Z-sequences of optical slices (3D image reconstruction) were obtained. 
To visualize viable fluorescent NIH3T3 cells and the photosensitizer inside, 488-nm and 633-nm 
lasers were used together: first one at 10% of its power to excite EGFP, expressed by cells, and 
the second one – at 15% to excite the fluorescence of Photosens. 
 
2.6 Fluorescence investigation of cell viability under the laser irradiation 
To visualize an effect of laser irradiation on NIH3T3/EGFP cells impregnated with pure 
and Photosens-loaded CaCO3 containers and Photosens solution, confocal laser scanning 
microscopy was applied. The control samples with NIH3T3/EGFP cells, incubated without 
any modifications, were also investigated. 
The cells were irradiated by Collimated Laser Diode CPS186 (Throlabs) at 670 nm with 
the power density of 19 mW/cm2 during 10 minutes meaning the light dose of 11.4 J/cm2. 
The beam cross-section area was set at 0.32 cm2 and the irradiated area was marked at the 
dish bottom. As far as the light doses of 6-12 J/cm2 do not induce intracellular ROS 
generation for NIH3T3 cells [51], the usage of such irradiation parameters should enable 
integrity of cells exposed to the light in absence of the photosensitizer allowing separation 
of the drug effect and exclusion of the laser damaging effect itself.  
All samples were visualized before and immediately after the irradiation using 
a confocal laser scanning microscope Leica TCS SP5 (Leica, Germany) at the same 
scanning parameters, as the cellular uptake investigation. 
 
2.7 Cytotoxicity assay 
For the cytotoxicity investigation the colorimetric MTT (3-(4-5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) assay [52] was used. Briefly, NIH3T3/EGFP cells were seeded in 
a 96-multi well plate and incubated with pure and Photosens-loaded submicron containers and 
Photosens solution as it was described above. Control wells inoculated with the cells were 
cultivated without any treatment. After 24 hours of incubation at 37 °C under 5% CO2 atmosphere 
with containers and solutions, cell layers were rinsed 3 times with PBS and incubated in growth 
medium. Half of the 96-multi well plate was irradiated well-by-well by the laser using the 
parameters described above (paragraph 2.6), thereupon the plate was incubated overnight at 37˚C 
under 5% CO2 and the toxicity test was carried out according to MTT protocol. Wherein, MTT 
powder was dissolved in PBS at a concentration of 5 mg/ml, the solution was subsequently filter-
sterilized. Twenty microliters of the solution were added to each well, including blank wells with 
no cells. After 3.5 hours of incubation, the media was carefully removed and 150 µl of Igepal 
CA-630 0.1% in 4 mM hydrochloric acid was added to the wells. Thereafter, the plate was covered 
with tinfoil and agitated on a shaker for 15 min. The absorbance was read at 590 nm by means of 
Multiskan Ascent 96/384 Plate Reader (MTX Lab Systems Inc., USA). The average absorbance 
of the blank wells, in which cells were omitted, was subtracted from the readings of the other wells. 
The average absorbance of the control untreated NIH3T3/EGFP cells, represented 100% cell 
survival. The relative cell viability (%) related to control cells was shown as “mean ± standard 
deviation’ of n=5 independent determinations. 
Statistical analysis was performed by one-way ANOVA on n = 5 independent samples 
followed by Tukey post-hoc test, significance was assigned at p-values <0.05. Equality of 
variances was checked using the F-test with a significant level of 0.05. 
 
3. Results and discussions 
3.1 Preparation of Photosens-loaded particles 
The wet synthesis of polycrystalline spherical vaterite particles under ultrasound (US) 
was applied [53]. This method is based on US-accomplished precipitation of CaCO3 from 
the saturated solutions of CaCl2 and Na2CO3 and allows the formation of porous particles 
with low dispersity, as far as ultrasonic field influences on crystallization process by 
enhancing the primary nucleation and preventing the agglomeration. In addition, this 
preparation technique was proven to be upscalable by virtue of the fact, that increment of 
the reaction volume enhanced the particle reaction yield without any significant losses in 
the sample quality [53]. 
The SEM image of obtained CaCO3 particles, presented in Figure 1 (a), demonstrates 
a spherical shape of the particles with an average size of 0.9±0.2 μm. Size distribution 
histogram is presented in Figure S1 (a) (see Supplementary Information). 
 
 
Figure 1. Scanning electron microscopy images of pure (a) and Photosens-loaded (b) CaCO3 
particles, confocal fluorescent image of Photosens-loaded CaCO3 particles (c) and XRD data of 
pure (black curve in d) and Photosens-loaded CaCO3 particles (blue curve in d), where red squares 
and numbers correspond to calcite peaks and miller indexes, black squares and numbers 
correspond to vaterite ones. 
 
A spherical shape of the particles indicates the vaterite phase of CaCO3, that was proved out 
by the XRD data presented in Figure 1d. The XRD pattern of pure CaCO3 particles (black curve 
in Figure 1d) exhibits the characteristic reflection for vaterite owning to the peaks corresponding 
to 020, 110, 120, 220, 211 planes (black squares and numbers in Figure 1d). The peaks, which are 
typical for calcite phase of CaCO3 (red squares and numbers in Figure 1d), were not observed on 
the XRD pattern. 
Photosensitizer-loaded CaCO3 particles were prepared by the US-assisted co-
precipitation method. In the co-precipitation technique, the drug is added to the reaction 
solution during calcium carbonate synthesis resulting in its entrapment into the structure of 
formed particles. In comparison with the physical adsorption technique, where the active 
substance should be adsorbed from the solution onto preformed particles, this method 
allows one to encapsulate five times higher amounts of biologically active substance. [47] 
Photosens (sulfonated aluminum phthalocyanine) was used as a photosensitizer, whereas 
this anticancer drug has been successfully applied in clinical practice since 2001 in both 
diagnostics and treatment. [42–46] 
The SEM and confocal fluorescent images of loaded containers (Figure 1 b, c) 
demonstrate the spherical shape of vaterite polycrystal particles with a size of 0.9±0.2 μm 
(size distribution histogram is presented in Figure S1b in Supplementary Information). The 
fluorescence signal from confocal microscopy in Figure 1 (c) demonstrated, that particles were 
successfully loaded with Photosens, preserving its fluorescence properties. As estimated by the 
spectrofluometric method, the loading capacity of containers corresponded to 0.12 % (w/w), that 
means 6 μg of Photosens incorporated to 5 mg of CaCO3 particles. The diffraction data for 
Photosens-loaded particles (blue curve in Figure 1d) demonstrate the presence of only vaterite 
phase, meaning that the addition of photosensitizer to the reaction mixture has no significant 
influence on crystallization process. 
 
3.2 Photosens release process 
Subsequently, release kinetic of Photosens from the containers was studied in water and 
in complete cell culture medium. 
As demonstrated previously [24,54,55], the release of the payload from the porous 
calcium carbonate particles is an interplay of drug desorption and carrier recrystallization. 
Being the least stable phase of CaCO3, vaterite slowly dissolves and recrystallizes to calcite 
form in contact with water, releasing the payload. Depending on the immersion medium, 
the vaterite particles dissolve or a crystal phase transition sets in, where the external layer 
of particles starts to ionize, seeding the formation of calcite monocrystals from the ions. 
The release curves of Photosens from containers were monitored via spectrofluorimetry 
and the corresponding calcium carbonate crystal phases were investigated via SEM for both 
immersion mediums. 
Observations started 5 min (0.83 hours) after immersion and lasted up to 7 days 
(168 hours). The main results, presented in SEM images (Figure 2), were found to be in 
good agreement with the release data, demonstrated in Figure 3. 
 
 
Figure 2. Scanning electron microscopy images of Photosens-loaded CaCO3 particles at different 
incubation time in water (top line a-c) and in cell medium (bottom line d-f): a, d – 24 hours, b, e – 48 
hours, c, f – 168 hours. The scale bars on main scans and insets for the top row of images correspond 
to 20 μm and to 5 μm, respectively; and to 5 μm and 2 μm for the bottom row. 
 
 
Figure 3. Release profiles of Photosens from porous CaCO3 submicron containers immersed in water and 
in cell medium during 7 days. The error bars represent standard error of the mean of release 
measurements for n=3 independent samples. 
 
The release of Photosens from the carriers is defined by desorption in the initial phase 
of incubation (during 5 minutes) and was followed by release during the recrystallization. 
Being immersed in either water or cell medium, CaCO3 particles released around 50% of 
loaded Photosens within 5 minutes (Figure 3) by desorption from the exterior particle 
surface. As a prevention of the premature payload release, a particle covering with 
a polyelectrolyte layer (polyethylene glycol e.g.) can be used when required [56]. Such 
a polymer deposition could inhibit the desorption of drug molecules without affecting 
the recrystallization kinetics of CaCO3 [57]. 
Fast recrystallization of CaCO3 containers from vaterite to calcite took place, while 
incubating in water. The transition sets in at around 24 hours (Figure 2 a), and correlates 
with previously reported results. [24] The external layer of particles was recrystallized to 
calcite, meanwhile for the inner part the process continued. The transition was completed 
after 48 hours of incubation, reflecting in 100% release of loaded Photosens during the 
formation of smooth calcite crystals (Figure 2b and Figure 3).  
In the cell medium the highest released percent of loaded Photosens (70±5%) was 
observed on the second day of incubation (Figure 3), when a small amount of cubic-like 
particles occurred (Figure 2 e). During 1 week of incubation in the cell medium the vaterite-
calcite recrystallization was not completed and the amount of cubic-like particles remained 
negligible (Figure 2f). This was reflected in the payload release profile (Figure 3): 
decreasing of released Photosens amount up to 62±5 % was observed, due to re-adsorption 
of Photosens molecules back on the surface of CaCO3 particles. 
Such delay of the recrystallization can be explained by the adsorption of proteins from 
the cell medium on the surface of CaCO3 carriers. A similar effect, called “corona”, was 
previously observed for different container types while its incubation in model solutions 
contained proteins. [58–60] The protein molecules stabilize the particle surface, and 
prevent recrystallization reflected as a slowdown of payload release. 
The prolongation of drug release from the vaterite submicron carriers can be considered 
as a beneficial advantage of the proposed system for in vivo application allowing the 
reduction of the payload loss in biological fluids (plasma, or otherwise), associated with 
the “protein corona” organized by biopolymers from the fluid. By this means, the drug 
release could be postponed up to the moment of delivery at the right site of action. 
Furthermore, this “protein corona” effect offers a novel strategy for targeted drug delivery 
owing to the modification of particle surface by specific proteins, which could provide its 
transportation and efficient cell internalization. [61] 
 
3.3 Cellular uptake 
For in vitro investigation of container uptake, cytotoxicity and phototoxicity, green 
fluorescent NIH3T3/EGFP cells were used. The median lethal dose (LD50) of Photosens 
(3 μg/ml) [50] was added to the cells both, in free and immobilized form into CaCO3 
particles, in order to investigate an effect of photosensitizer encapsulation. 
The uptake process analysis was performed by confocal laser scanning microscopy and 
the images are represented in Figure 4. 
 
 
Figure 4. Fluorescent confocal images, including 3D reconstruction (c, d), of NIH3T3/EGFP cells 
after 24 hours of incubation with Photosens solution (a, c) and with Photosens-loaded CaCO3 
particles (b, d). 
 
3D stacks of fluorescent images (Figure 4 c, d) demonstrated that the photosensitizer 
was uniformly distributed inside the cells (Figure 4 c) or was localized also inside the 
carriers trapped by cells (bright red spots within the cells at Figure 4 d). Thus, CaCO3 
particles loaded with Photosens and captured by cells provided dye localization inside the 
cell increasing its local concentration, compared with “free” Photosens solution. The uptake 
within 24 hours was found to be equal to 44 ± 5 containers per cell. 
In order to evaluate the amount of Photosens, which had been trapped by cells within 
24 hours, and the percentage in spread and localized state, the supernatant from the cells 
after the container incubation was collected for fluorometric investigation. Subsequent 
analysis of the data and calculations (see Supplementary Information) have established, 
that 85% of added ‘free’ Photosens was entrapped by cells, compared to 53% with 
Photosens-loaded particles. According to the Photosens release profile (Figure 3, 24 hours 
in cell medium), 70% of the amount loaded into CaCO3 particles was released by that time. 
Taking that loss into account, we estimated the possible range of captured amount of 
Photosens localized inside the containers while delivered into cells in the time course. 
The lower value of estimated drug amount ( 	 	 	 ) reflects the 
instantaneous cellular uptake of the particles containing 30% of loaded photosensitizer as 
particles release the drug before uptake: 
	 	 	 = 0.3 ×
%
100% × 	 	
(4) 
where 	  – the mass of Photoses-loaded CaCO3 particles entrapped by 
cells during 24 hours (see Supplementary Information). 
Whereas the upper estimation ( 	 	 	 ) considers no release of the drug 
before the uptake and hence the 100%-loading of captured containers: 
	 	 	 =
%
100% × 	 	
(5) 
This means, 5-18% of the photosensitizer remained inside the CaCO3 particles after 24-hours 
uptake by cells, while the rest of the entrapped Photosens had been released from the containers 
and subsequently spread inside the cell interior. 
 
3.4 Cellular phototoxicity under the laser irradiation: fluorescence investigation and 
toxicity assay 
Photosens-loaded and pure CaCO3 particles, as well as “free” Photosens solution, were 
incubated with NIH3T3/EGFP cells for 24 hours. Then cells were carefully washed and 
irradiated by the laser with a wavelength corresponding to the Photosens adsorption 
maximum (670 nm) for 10 minutes. The effect of laser irradiation on cells was investigated 
by confocal laser scanning microscopy before and after the irradiation (Figure 5) and 
estimated by MTT assay (Figure 6). 
 
 
Figure 5. Confocal fluorescent images of NIH3T3/EGFP cells before (a-d) and after irradiation (e-
h): control cells (a, e), cells impregnated with pure (b, f) and Photosens-loaded (c, g) CaCO3 
particles, cells cultured with Photosens solution (d, h). The scale bar is equal to 50 μm 
 
 
Figure 6. Cytotoxic effect of calcium carbonate particles (control CaCO3), “free” Photosens 
solution (PS) and Photosen-loaded CaCO3 particles (CaCO3+PS) on NIH3T3/EGFP cells without 
(light grey columns) and with (dark grey columns) laser irradiation. The concentration of pure and 
loaded CaCO3 particles was 0.25 mg/ml, the corresponding Photosens concentration was 3 μg/ml. 
The cell viability was determined by MTT metabolism assay and shown as “mean ± standard 
deviation” of n=5 independent determinations. An asterisk (*) indicates significant differences from 
the control cell group. An ampersand (&) denotes significant differences between irradiated and not 
irradiated samples containing Photosens. A caret (^) indicates a significant difference in cell 
viability under the irradiation between the samples pretreated with encapsulated and “free” 
Photosens forms. The statistical analysis was performed by ANOVA followed by the Tukey test 
(P<0.05)). 
 
As was reported before, the death of EGFP expressing cells could be observed by 
the decrease of their fluorescence. [62] Thereby, the fluorescence investigation of 
NIH3T3/EGFP before and after the laser irradiation allows the visualization of an effect of 
this irradiation: the bright green signal images only the cells, which are alive and maintain 
EGFP expression, meanwhile dead cells have no fluorescence in a green channel. 
Comparison of the fluorescence of “control” cells and cells treated with pure CaCO3 
particles before (Figure 5 a, b) and after irradiation (Figure 5 e, f) demonstrated, that 
the application of CaCO3 particles, even at a high concentration (1 mg/cm2 of dish surface), 
as well, as laser irradiation, didn’t affect cell viability in the absence of photosensitizer. 
This effect was borne out by the MTT assay which demonstrated a high average survival 
rate of NIH3T3/EGFP cells (Figure 6). 
The uptake of Photosens in “free” form (Figure 5 d, h) and immobilized into CaCO3 
particles (Figure 5 c, g) by NIH3T3/EGFP cells caused the loss of the fluorescent signal in 
a green channel under laser irradiation. The red spots on these confocal images denote 
the fluorescent signal in a red channel from the entrapped Photosens and therefore indicate 
the presence of the cells in the field of view. The overlay of both fluorescent channels 
allowed the distinction between alive (Figure 5 c, d) and dead (Figure 5 g, h) 
NIH3T3/EGFP cells, and by this means illustrated a phototoxic effect for both, Photosens 
solution and Photosens immobilized into CaCO3 particles. 
Significant phototoxic effect was also demonstrated using the MTT assay for immobilized and 
free Photosens (Figure 6). A drastic difference in the percentage of viable cells was observed: 
2% versus 20%, correspondently. Moreover, the release investigation demonstrated, that by the 
time of irradiation a higher photosensitizer amount had been entrapped by NIH3T3/EGFP cells 
from Photosens solution (85%), than from Photosens-loaded particles (53%). By this means, 
CaCO3 particles loaded with Photosens proved to be almost 20-times more effective compared to 
“free” Photosens solution. Increasing the local concentration of a drug inside the cell, CaCO3 
particles are capable of decreasing its concentration in the system, and therefore, potentially allow 
the reduction of therapeutic dose. 
 
4. Conclusions 
In the current work, we have proposed a novel platform for anticancer PDT. 
The platform is based on Photosens-loaded calcium carbonate submicron particles 
fabricated by ultrasound-assisted co-precipitation method. By virtue of the demonstration, 
the photosensitizer release from the carriers arises mostly from the vaterite-calcite 
recrystallization of CaCO3. Sustained release has been achieved by suppression of 
recrystallization as a result of particle surface stabilization with proteins from the cell 
medium. Such effect holds out the prospect of in vivo application of the proposed system, 
since it allows a reduction of the payload loss in biological fluids, associated with the 
“protein corona” organized by biopolymers from the fluid. The cellular uptake experiments 
have demonstrated fast penetration of the Photosens-loaded particles into NIH3T3/EGFP 
cells. The captured carriers have provided dye localization inside cells increasing its local 
concentration compared with delivery from “free” Photosens solution uniformly distributed 
throughout the cell. Significant phototoxic effect was discovered for both, Photosens 
solution and for CaCO3 particles loaded with Photosens, meanwhile the irradiation alone 
had no influence on cell viability in the absence of the photosensitizer. The biocompatibility 
of pure CaCO3 particles was demonstrated, since they did not influence cell viability. 
According to MTT results, CaCO3 particles loaded with Photosen were almost 20-times 
more effective compared to “free” Photosens solution at killing cells. Improving the drug 
effectiveness, CaCO3 particles potentially support the reduction of its therapeutic dose. 
This effect has revealed the promising outlook of the proposed system for application in 
PDT, as well as in nanomedicine in general, since it might overcome non-specific toxicity 
in healthy tissue caused by using a high dose. At the same time, simplicity, upscalability 
and cheapness of the fabrication, biocompatibility and high payload ability of the vaterite 
particles open up perspectives beyond the scope of cancer treatment. 
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